Evidence map›Paper›PMID 26216977›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Baculovirus protein PK2 subverts eIF2α kinase function by mimicry of its kinase domain C-lobe.

John J Li, Chune Cao, Sarah M Fixsen, Janet M Young, Chikako Ono, Hisanori Bando, Nels C Elde, Susumu Katsuma, Thomas E Dever, Frank Sicheri

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Viral evasion of PKR restriction by reprogramming cellular stress granules.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

John J LiProgram in Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada;
Chune CaoLaboratory of Gene Regulation and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Sarah M FixsenDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112;
Janet M YoungDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109;
Chikako OnoLaboratory of Applied Molecular Entomology, Division of Agrobiology, Graduate School of Agriculture, Hokkaido University, Sapporo 060-8589, Japan; katsuma@ss.ab.a.u-tokyo.ac.jp tdever@nih.gov sicheri@lunenfeld.ca.
Hisanori BandoLaboratory of Applied Molecular Entomology, Division of Agrobiology, Graduate School of Agriculture, Hokkaido University, Sapporo 060-8589, Japan;
Nels C EldeDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112;
Susumu KatsumaDepartment of Agricultural and Environmental Biology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan; katsuma@ss.ab.a.u-tokyo.ac.jp tdever@nih.gov sicheri@lunenfeld.ca.
Thomas E DeverLaboratory of Gene Regulation and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; katsuma@ss.ab.a.u-tokyo.ac.jp tdever@nih.gov sicheri@lunenfeld.ca.
Frank SicheriProgram in Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada; Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada katsuma@ss.ab.a.u-tokyo.ac.jp tdever@nih.gov sicheri@lunenfeld.ca.
Hokkaido University · JPNational Institutes of Health · USUniversity of Utah · USFred Hutch Cancer Center · USLunenfeld-Tanenbaum Research Institute · CAThe University of Tokyo · JPUniversity of Toronto · CA

Funding

Mechanism and Regulation of Eukaryotic Protein SynthesisZIAHD001010 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DEVER, THOMAS E · 2009 to 2025
$29.4M
Training CoreP50GM107632 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BURNS, KATHLEEN H · 2013 to 2017
$10.0M
TRAINING PROGRAM IN GENETICST32GM007464 · NIGMS · UNIVERSITY OF UTAH · PI GRUNWALD, DAVID J., STANFIELD, GILLIAN · 1985 to 2020
$6.1M
Evolutionary potential of a model poxvirusR00GM090042 · NIGMS · UNIVERSITY OF UTAH · PI ELDE, NELS C. · 2011 to 2013
$728k
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
Evolutionary potential of a model poxvirusK99GM090042 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ELDE, NELS C. · 2010 to 2011
$135k
Canadian Institutes of Health Research MOP-84370Intramural NIH HHSNIGMS NIH HHS GM090042NIGMS NIH HHS K99 GM090042NIGMS NIH HHS P50 GM107632NIGMS NIH HHS R00 GM090042NIGMS NIH HHS T32 GM007464NIH HHS S10 OD020069
6 · The paper itself

Abstract

Phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) by eIF2α family kinases is a conserved mechanism to limit protein synthesis under specific stress conditions. The baculovirus-encoded protein PK2 inhibits eIF2α family kinases in vivo, thereby increasing viral fitness. However, the precise mechanism by which PK2 inhibits eIF2α kinase function remains an enigma. Here, we probed the mechanism by which PK2 inhibits the model eIF2α kinase human RNA-dependent protein kinase (PKR) as well as native insect eIF2α kinases. Although PK2 structurally mimics the C-lobe of a protein kinase domain and possesses the required docking infrastructure to bind eIF2α, we show that PK2 directly binds the kinase domain of PKR (PKR(KD)) but not eIF2α. The PKR(KD)-PK2 interaction requires a 22-residue N-terminal extension preceding the globular PK2 body that we term the "eIF2α kinase C-lobe mimic" (EKCM) domain. The functional insufficiency of the N-terminal extension of PK2 implicates a role for the adjacent EKCM domain in binding and inhibiting PKR. Using a genetic screen in yeast, we isolated PK2-activating mutations that cluster to a surface of the EKCM domain that in bona fide protein kinases forms the catalytic cleft through sandwiching interactions with a kinase N-lobe. Interaction assays revealed that PK2 associates with the N- but not the C-lobe of PKR(KD). We propose an inhibitory model whereby PK2 engages the N-lobe of an eIF2α kinase domain to create a nonfunctional pseudokinase domain complex, possibly through a lobe-swapping mechanism. Finally, we show that PK2 enhances baculovirus fitness in insect hosts by targeting the endogenous insect heme-regulated inhibitor (HRI)-like eIF2α kinase.

Indexed as

Molecular MimicryAnimalsBaculoviridaeBombyxCell LineDNA Mutational AnalysiseIF-2 KinaseModels, MolecularMutationProtein BindingProtein Structure, TertiarySaccharomyces cerevisiaeSequence Homology, Amino AcidStructure-Activity RelationshipViral Proteinsbaculovirus PK2eIF-2 KinaseViral ProteinseIF2α kinase inhibitionHRIlobe-swapPKRviral mimicry

Identifiers

PMID26216977
PMCPMC4538665
OpenAlexW2138486607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.